ArticleScientific reports2026
Correlation between fecal eosinophil cationic protein and cow's milk protein allergy in extremely preterm infants and its value in auxiliary diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To explore the correlation between fecal Eosinophil Cationic Protein (ECP) and Cow's Milk Protein Allergy (CMPA) in extremely preterm infants, and to evaluate its value in auxiliary diagnosis. This prospective controlled study enrolled 60 extremely preterm infants (< 32 weeks gestational age), comprising 30 with confirmed CMPA and 30 matched controls. Fecal ECP levels and routine blood tests were monitored longitudinally. Statistical analyses included one-way repeated-measures ANOVA and independent samples t-test. Fecal ECP levels in the experimental group were significantly elevated during allergic manifestation (7.08 ± 1.22 µg/g) compared with all other timepoints (all P < 0.001). No significant differences in ECP levels were observed among non-allergic timepoints (all P > 0.05). The control group maintained stable ECP levels throughout all observed periods (P > 0.05). The mean fecal ECP level during non-allergic periods in the experimental group (3.18 ± 1.01 µg/g) showed no significant difference from the control group (P = 0.262). In contrast, ECP levels during active allergy were significantly higher than those in the control group (P < 0.001). Fecal ECP level is significantly positively correlated with CMPA onset in extremely preterm infants, which provides a clinical basis for non-invasive auxiliary diagnosis of CMPA in extremely preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.